Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Mefenamic acid poisoning (disorder) |
Causative agent (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental mefenamic acid poisoning |
Causative agent (attribute) |
False |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional mefenamic acid poisoning (disorder) |
Causative agent (attribute) |
False |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par l'acide méfénamique d'intention indéterminée |
Causative agent (attribute) |
False |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid adverse reaction |
Causative agent (attribute) |
False |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to mefenamic acid |
Causative agent (attribute) |
False |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mefenamic acid overdose (disorder) |
Causative agent (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental mefenamic acid overdose (disorder) |
Causative agent (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional mefenamic acid overdose |
Causative agent (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose d'acide méfénamique d'intention indéterminée |
Causative agent (attribute) |
False |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid [cns analgesic] [see j2b..] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mefenamic acid [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mefenamic acid 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mefenamic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mefenamic acid 50mg/5mL pediatric suspension (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing mefenamic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adverse reaction caused by mefenamic acid (disorder) |
Causative agent (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental mefenamic acid poisoning |
Causative agent (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional mefenamic acid poisoning (disorder) |
Causative agent (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to mefenamic acid |
Causative agent (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid 250 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid 250 mg oral capsule |
Has precise active ingredient |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid 500 mg oral tablet |
Has precise active ingredient |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid 10 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid 10 mg/mL oral suspension |
Has precise active ingredient |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only mefenamic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Drotaverine- and mefenamic acid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drotaverine and mefenamic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drotaverine- and mefenamic acid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drotaverine and mefenamic acid only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing mefenamic acid and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid and paracetamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid- and paracetamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid 10 mg/mL and paracetamol 25 mg/mL oral suspension |
Has precise active ingredient |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Mefenamic acid 10 mg/mL and paracetamol 25 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dicycloverine and mefenamic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dicycloverine and mefenamic acid only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely dicycloverine hydrochloride 10 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dicycloverine hydrochloride 10 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing dicycloverine and mefenamic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing dicycloverine and mefenamic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely mefenamic acid 500 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mefenamic acid 500 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mefenamic acid 500 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mefenamic acid 500 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid 250 mg oral tablet |
Has precise active ingredient |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid 250 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |